Thyrotropin injection
Products billed under this code include Thyrogen.
Payment limit per 0.9 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Thyrogen.
Payment limit per 0.9 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Thyrogen | Genzyme Corporation | 58468-0030-02 | 2 | $4,310.224 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $2,155.112 | −$3.549 | 0.9 MG | Thyrotropin injection | v1, posted September 17, 2026 |
| 3Q26 | $2,158.661 | +$33.324 | 0.9 MG | Thyrotropin injection | v1, posted September 15, 2026 |
| 2Q26 | $2,125.337 | −$0.299 | 0.9 MG | Thyrotropin injection | v1, posted September 15, 2026 |
| 1Q26 | $2,125.636 | +$9.313 | 0.9 MG | Thyrotropin injection | v1, posted September 15, 2026 |
| 4Q25 | $2,116.323 | +$3.085 | 0.9 MG | Thyrotropin injection | v1, posted September 8, 2026 |
| 3Q25 | $2,113.238 | +$34.527 | 0.9 MG | Thyrotropin injection | v1, posted March 10, 2026 |
| 2Q25 | $2,078.711 | +$10.803 | 0.9 MG | Thyrotropin injection | v1, posted March 10, 2026 |
| 1Q25 | $2,067.908 | −$5.433 | 0.9 MG | Thyrotropin injection | v1, posted December 19, 2025 |
| 4Q24 | $2,073.341 | +$7.502 | 0.9 MG | Thyrotropin injection | v1, posted June 11, 2025 |
| 3Q24 | $2,065.839 | +$43.473 | 0.9 MG | Thyrotropin injection | v1, posted June 11, 2025 |
| 2Q24 | $2,022.366 | +$1.196 | 0.9 MG | Thyrotropin injection | v1, posted March 11, 2025 |
| 1Q24 | $2,021.17 | +$9.905 | 0.9 MG | Thyrotropin injection | v1, posted December 19, 2024 |
| 4Q23 | $2,011.265 | +$9.78 | 0.9 MG | Thyrotropin injection | v1, posted October 10, 2024 |
| 3Q23 | $2,001.485 | +$74.742 | 0.9 MG | Thyrotropin injection | v1, posted June 5, 2024 |
| 2Q23 | $1,926.743 | +$1.802 | 0.9 MG | Thyrotropin injection | v1, posted February 23, 2024 |
| 1Q23 | $1,924.941 | −$1.773 | 0.9 MG | Thyrotropin injection | v1, posted December 6, 2023 |
| 4Q22 | $1,926.714 | +$19.781 | 0.9 MG | Thyrotropin injection | v1, posted June 22, 2023 |
| 3Q22 | $1,906.933 | +$48.27 | 0.9 MG | Thyrotropin injection | v1, posted June 9, 2023 |
| 2Q22 | $1,858.663 | +$0.623 | 0.9 MG | Thyrotropin injection | v1, posted December 14, 2022 |
| 1Q22 | $1,858.04 | +$20.794 | 0.9 MG | Thyrotropin injection | v1, posted June 8, 2022 |
| 4Q21 | $1,837.246 | −$3.938 | 0.9 MG | Thyrotropin injection | v1, posted June 2, 2022 |
| 3Q21 | $1,841.184 | +$66.853 | 0.9 MG | Thyrotropin injection | v1, posted June 2, 2022 |
| 2Q21 | $1,774.331 | −$1.881 | 0.9 MG | Thyrotropin injection | v1, posted March 1, 2022 |
| 1Q21 | $1,776.212 | – | 0.9 MG | Thyrotropin injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.